...
首页> 外文期刊>Hypertension: An Official Journal of the American Heart Association >Involvement of Aldosterone and Mineralocorticoid Receptors in Rat Mesangial Cell Proliferation and Deformability
【24h】

Involvement of Aldosterone and Mineralocorticoid Receptors in Rat Mesangial Cell Proliferation and Deformability

机译:醛固酮和盐皮质激素受体参与大鼠肾小球系膜细胞增殖和变形

获取原文

摘要

We demonstrated recently that chronic administration of aldosterone to rats induces glomerular mesangial injury and activates mitogen-activated protein kinases including extracellular signal-regulated kinases 1/2 (ERK1/2). We also observed that the aldosterone-induced mesangial injury and ERK1/2 activation were prevented by treatment with a selective mineralocorticoid receptor (MR) antagonist, eplerenone, suggesting that the glomerular mesangium is a potential target for injuries induced by aldosterone via activation of MR. In the present study, we investigated whether MR is expressed in cultured rat mesangial cells (RMCs) and involved in aldosterone-induced RMC injury. MR expression and localization were evaluated by Western blotting analysis and fluorolabeling methods. Cell proliferation and micromechanical properties were determined by [3H]-thymidine uptake measurements and a nanoindentation technique using an atomic force microscope cantilever, respectively. ERK1/2 activity was measured by Western blotting analysis with an anti-phospho–ERK1/2 antibody. Protein expression and immunostaining revealed that MR was abundant in the cytoplasm of RMCs. Aldosterone (1 to 100 nmol/L) dose-dependently activated ERK1/2 in RMCs with a peak at 10 minutes. Pretreatment with eplerenone (10 μmol/L) significantly attenuated aldosterone-induced ERK1/2 phosphorylation. Aldosterone (100 nmol/L) treatment for 30 hours increased [3H]-thymidine incorporation and decreased the elastic modulus, indicating cellular proliferative and deforming effects of aldosterone, respectively. These aldosterone-induced changes in cellular characteristics were prevented by pretreatment with eplerenone or an ERK (MEK) inhibitor, PD988059 (100 μmol/L). The results indicate that aldosterone directly induces RMC proliferation and deformability through MR and ERK1/2 activation, which may contribute to the pathogenesis of glomerular mesangial injury.
机译:我们最近证明,向大鼠长期施用醛固酮会诱发肾小球系膜损伤并激活丝裂原活化的蛋白激酶,包括细胞外信号调节激酶1/2(ERK1 / 2)。我们还观察到,用选择性盐皮质激素受体(MR)拮抗剂依普利农治疗可预防醛固酮诱导的肾小球系膜损伤和ERK1 / 2激活,提示肾小球系膜是通过激活MR醛固酮引起的损伤的潜在靶标。在本研究中,我们调查了MR是否在培养的大鼠系膜细胞(RMC)中表达并参与了醛固酮诱导的RMC损伤。通过蛋白质印迹分析和荧光标记法评估MR的表达和定位。通过[3 H]-胸苷摄取测量和使用原子力显微镜悬臂的纳米压痕技术分别测定细胞增殖和微机械性能。 ERK1 / 2活性通过抗磷酸化-ERK1 / 2抗体的蛋白质印迹分析进行了测量。蛋白表达和免疫染色显示,MRC在细胞质中含量丰富。醛固酮(1至100 nmol / L)剂量依赖性地激活RMC中的ERK1 / 2,在10分钟时达到峰值。依普利农(10μmol/ L)预处理显着减弱了醛固酮诱导的ERK1 / 2磷酸化。醛固酮(100 nmol / L)处理30小时可增加[3H]-胸苷的掺入并降低弹性模量,分别表明醛固酮的细胞增殖和变形作用。这些醛固酮诱导的细胞特征变化可通过依普利农或ERK(MEK)抑制剂PD988059(100μmol/ L)进行预处理来预防。结果表明,醛固酮通过MR和ERK1 / 2激活直接诱导RMC增殖和变形,这可能是肾小球系膜损伤的发病机制。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号